TITLE

Influence of Pentoxifylline on Muscle Tissue Oxygen Tension (pO2) of Patients with Intermittent Claudication Before and After Pedal Ergometer Exercise

AUTHOR(S)
Ehrly, A. M.; Saeger-Lorenz, K.
PUB. DATE
February 1987
SOURCE
Angiology;Feb1987 Part 1, Vol. 38 Issue 2, p93
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, Intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo). The tissue oxygen tension (pO2) response (pO2 kinetics) following treatment with placebo revealed a nominal but statistically nonsignificant increase in arithmetic mean and median pO2 immediately after the end of exercise. Values thereafter reverted approximately to the Initial values recorded at rest. Comparison of the pooled pO2 histograms during the individual periods before and after the end of exercise, however, revealed a broadening of the histogram base, reflecting both higher pO2 values and, more particularly, increased numbers of hypoxic and anoxic pO2 values. This Is interpreted as an expression of nonhomogeneous capillary perfusion (maldistribution). Following administration of pentoxifylline to the same patients, there was a statistically significant increase in mean and median pO2 at ten and twenty minutes after the end of exercise. Even after thirty and sixty minutes, these values were in some cases still clearly higher than the Initial preexercise values. Study of the pooled PO2 histograms discloses a right shift compared with the Initial preexercise histograms. This suggests that pentoxifylline exerts a positive effect on maldistribution by making capillary perfusion more homogeneous. The results support the conclusion that, in the context of reactive hyperemia after muscular exercise, tissue oxygen supply is markedly improved by pentoxifylline in comparison with saline solution. The measurement of tissue pO2 before and at intervals after pedal ergometer exercise is a new objective technique for assessing the efficacy of blood flow-promoting therapy, permitting close simulation of the pathophysiological situation in the muscles of the lower leg in intermittent claudication.
ACCESSION #
16478968

 

Related Articles

  • Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication? Weismantel, David // Journal of Family Practice;Feb2001, Vol. 50 Issue 2, p181 

    This article presents a study which examined the effectiveness of cilostazol over pentoxifylline in the treatment of symptoms of intermittent claudication. The study population is composed of patients with stable moderate to severe symptoms of intermittent claudication and confirmed peripheral...

  • Effects of Cilostazol and Pentoxifylline on Forearm Reactive Hyperemia Response, Lipid Profile, Oxidative Stress, and Inflammatory Markers in Patients With Intermittent Claudication. de Albuquerque, Renato Maranhão; Virgini-Magalhães, Carlos Eduardo; Sicuro, Fernando Lencastre; Bottino, Daniel Alexandre; Bouskela, Eliete // Angiology;Oct/Nov2008, Vol. 59 Issue 5, p549 

    Peripheral arterial disease may lead to lower limb claudication and increased risk of systemic vascular dysfunction. In this article, the authors have investigated the peripheral vascular dysfunction evaluating forearm blood flow using venous occlusion plethysmography, lipid profile, and...

  • Cilostazol cost effective for intermittent claudication in the UK.  // PharmacoEconomics & Outcomes News;7/2/2005, Issue 481, p5 

    Provides information on research regarding the use of cilostazol in patients with intermittent claudication. Cost effectiveness of the drug; Improvement in maximal walking distance of patients treated with cilostazol; Treatment costs for cilostazol compared with naftidrofuryl and pentoxifylline.

  • Pentoxifylline and Intermittent Claudication. Spittell, John A. // Annals of Internal Medicine;Jan85, Vol. 102 Issue 1, p126 

    Reports that the U.S. Food and Drug Administration approved as of January 1985, the use of pentoxifylline, a methylxanthine with vasoactive properties for the symptomatic treatment of intermittent claudication due to chronic occlusive peripheral arterial disease. Recommended dose; Alternative...

  • Effects of Pentoxifylline on Severe Intermittent Claudication. Reich, Theobald; Gilings, Dennis // Angiology;Sep1987, Vol. 38 Issue 9, p651 

    Pentoxifylline has been shown to improve treadmill walking distances under blinded, controlled conditions in patients with intermittent claudication. From the pooled data of a blinded, controlled, randomized, multicenter trial, the data from all enrolled patients with severe claudication (< 70 m...

  • Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication. Crowder, John E.; Cohn, Jay B.; Savitsky, J. Philip; Morgan, DeAnn L.; Slywka, Joseph; Cobert, Barton L.; Hryniewicki, Stephen W.; Piccirillo, Ronald T.; Wilcox, Charles S. // Angiology;Sep1989, Vol. 40 Issue 9, p795 

    The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up...

  • Evaluation of pentoxifylline effect in treatment of ankylosis spondylitis patients referred to Rasool-e- Akram Hospital. Shirani, Fatemeh; Mehdi Sebt Rozati, Seyed // Razi Journal of Medical Sciences;Aug/Sep2011, Vol. 18 Issue 87, p8 

    Background: Ankylosing spondylitis (AS) is a spondyloarthropathy of unknown etiology, with widespread effect on axial and peripheral skeleton. The aim of this study was determination of pentoxifylline effect on Bath Ankylosing spondylitis Disease Activity Index (BASDAI) of uncontrolled AS...

  • Efficacy of Cilostazol for Intermittent Claudication. Apgar, Barbara // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1124 

    Discusses the study `A New Pharmacological Treatment for Intermittent Claudication: Results of a Randomized, Multicenter Trial,' by H.G. Beebe and colleagues published in the September 27, 1999 issue of the `Archives of Internal Medicine.'

  • CORRESPONDENCE. Dawber, Rodney; MacGowan, Alastair P.; Johnston, Peter W.; Thomson, Angus W.; Harris, P.F.; Elwood, J. Mark; Longhore, H.J.A.; Dunn, Ailsa M; Buckley, Brendan M.; Axford, J.S.; Berry, H.; Stewart, Gordon T.; Williams, Gareth; Pickup, John; Petitti, Diana B.; Beverly, Michael C.; Evans, Michael J.; Bone, P.J. // British Medical Journal (Clinical Research Edition);7/19/1986, Vol. 293 Issue 6540, p201 

    Focuses on health related issues in Europe. Association of hyponatremia with non-steroidal anti-inflammatory drugs; Alteration of thyroid function following treatment with fenoprofen; Derivation of transcutaneous oxygen tension during exercise in patients with claudication.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics